Supplement Industry Waits For “Friendlier” MedWatch Form
This article was originally published in The Tan Sheet
Executive Summary
FDA changes MedWatch form 3500A to accommodate medical device firms’ needs, but will not make changes to facilitate reporting AERs for drug, supplement or food products. The agency and supplement industry stakeholders agree 3500A is not ideal for supplement AERs.
You may also be interested in...
Burton Bill Would Move Up New Dietary Ingredient Grandfather Date To 2007
Rep. Burton offers legislation to move up from 1994 to 2007 the date delineating old from new dietary ingredients. Despite the appeal, supplement trade groups are leery of opening up DSHEA to amendment.
FDA Says Supplement Adverse Event Under-Reporting Should Feed Growth
FDA published a how-to guide to push dietary supplement firms toward tighter compliance with the requirement to submit serious adverse event reports to the agency.
US DoJ Has 'Key Focus' On Supplement Industry, Adds 6 Attorneys To Sector
"It is just common sense that there's going to be fraud where you have the combination of high growth, developing science, imported products or ingredients and limited oversight," says David Morrell, deputy assistant US attorney in DoJ'd Consumer Protection Branch. CPB is adhering to executive order President Trump made earlier in 2019 instructing federal agencies to enforced based on regulations, not on guidance.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: